Koninklijke Philips (PHG) Income from Non-Controlling Interests (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Income from Non-Controlling Interests of $2.3 million for Q2 2026, up 168.46% year-over-year from $865956.9 in Q2 2025, and up 139.71% quarter-over-quarter from -$5.9 million in Q1 2026.
Koninklijke Philips (PHG) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Koninklijke Philips' Income from Non-Controlling Interests history runs 18 years deep, the most recent figure standing at $2.3 million for Q2 2026.
- In Q2 2026, Income from Non-Controlling Interests rose 168.46% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at -$2.4 million (up 27.15% YoY), while the FY2025 annual figure was $1.2 million, down 63.69% from the prior year.
- Income from Non-Controlling Interests for Q2 2026 stood at $2.3 million, up from -$5.9 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $4.4 million in Q3 2023, with the low at -$5.9 million in Q1 2026.
- The 5-year median for Income from Non-Controlling Interests is $2.1 million (2024), against an average of $337618.6.
- The sharpest annual moves came in 2023 and 2025: Income from Non-Controlling Interests jumped 331.86% in 2023, then plunged 257.67% in 2025.
- Koninklijke Philips' Income from Non-Controlling Interests stood at $1.0 million in 2022, then surged by 331.86% to $4.4 million in 2023, then slumped by 49.56% to $2.2 million in 2024, then increased by 5.99% to $2.3 million in 2025, then declined by 0.14% to $2.3 million in 2026.
- Business Quant data shows PHG's Income from Non-Controlling Interests at $2.3 million in Q2 2026, -$5.9 million in Q1 2026, and $2.3 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 19.20 Bn | 18.79 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.32 Mn |
| Mar 31, 2026 | -5.85 Mn |
| Dec 31, 2025 | 2.33 Mn |
| Sep 30, 2025 | -1.17 Mn |
| Jun 30, 2025 | -3.40 Mn |
| Mar 31, 2025 | -4.21 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Sep 30, 2023 | 4.35 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 2.13 Mn |
| Dec 31, 2021 | -6.86 Mn |
| Sep 30, 2021 | 8.26 Mn |
| Jun 30, 2021 | 2.41 Mn |
| Mar 31, 2021 | 1.21 Mn |
| Dec 31, 2020 | 4.77 Mn |
| Sep 30, 2020 | 2.34 Mn |
| Jun 30, 2020 | 2.20 Mn |
| Mar 31, 2020 | 1.10 Mn |